Compare ABX & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABX | INMD |
|---|---|---|
| Founded | 2004 | 2008 |
| Country | United States | Israel |
| Employees | 326 | N/A |
| Industry | Investment Managers | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 840.3M | 842.0M |
| IPO Year | N/A | 2018 |
| Metric | ABX | INMD |
|---|---|---|
| Price | $9.46 | $14.90 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 5 |
| Target Price | $9.50 | ★ $17.33 |
| AVG Volume (30 Days) | 465.5K | ★ 605.2K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.13% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $19.18 | $1.74 |
| Revenue Next Year | $14.60 | $3.26 |
| P/E Ratio | $74.88 | ★ $10.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.18 | $12.72 |
| 52 Week High | $10.54 | $16.74 |
| Indicator | ABX | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 53.07 | 71.45 |
| Support Level | $8.20 | $14.58 |
| Resistance Level | $9.71 | $15.33 |
| Average True Range (ATR) | 0.36 | 0.21 |
| MACD | 0.04 | 0.09 |
| Stochastic Oscillator | 69.35 | 91.11 |
Abacus Global Management Inc is a financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. The company operates through four distinct yet complementary divisions: Abacus Life Solutions, Abacus Asset Group, Abacus Intel, and Abacus Wealth Advisors. It operates through three reportable segments, Asset management, Life solutions, and Technology services. It derives the majority revenue from Life solutions segment that generates revenues by buying, selling, and trading policies, and maintaining policies until receipt of death benefits. It also generates revenue by originating life insurance policy settlements between investors or buyers, and the sellers, who is often the original policy owner.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.